General Statement of Disclosure:

CONSULTING FEES/HONORARIA: United Healthcare Scientific Advisory Board(MODEST), Novartis(SIGNIFICANT), Janssen Pharmaceuticals, Inc(SIGNIFICANT), Eli Lilly and Company(MODEST), terumo(MODEST), Pfizer Inc(NONE), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), alnylam(SIGNIFICANT), Merck & Co., Inc.(MODEST), AstraZeneca Pharmaceuticals(MODEST) OFFICER, DIRECTOR ETC: Blue Cross Blue Shield of Kansas City(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Copyright for SAQ, KCCQ and PAQ(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: American College of Cardiology Foundation(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Abbott Laboratories(MODEST)

View Full Disclosure